GL1X · GenesisL1 explorer

Ligand · BVI

BVI · 8-cyclopropyl-N-[5-methyl-1-(oxan-4-yl)-1H-pyrazol-4-yl]quinazolin-2-amine

BVI, 8-cyclopropyl-N-[5-methyl-1-(oxan-4-yl)-1H-pyrazol-4-yl]quinazolin-2-amine (C20 H23 N5 O, 349.4 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1 PDB entry). Every binding site with its residues within 4.5 Å, the…

Component
BVI
Formula
C20 H23 N5 O
Class
ligand
Structures
2
PDB entries
1

Binding sites

BVI in 2 structures; the first of them:

  • 7SUF · Structure of CHK1 10-pt. mutant complex with LRRK2 inhibitor 06 · BVI A301 · binds GLN13, LEU15, TYR20, VAL23, ALA36, ILE68, MET84, GLU85 and 5 more
  • 7SUF · Structure of CHK1 10-pt. mutant complex with LRRK2 inhibitor 06 · BVI A301 · binds GLN13, LEU15, VAL23, ALA36, GLU85, LEU86, ALA87, SER88 and 2 more

Residues it binds most

LEU 2, ALA 2, GLN 2, GLU 2, GLY 2, SER 2, VAL 2, ILE 1, MET 1, TYR 1 (residue and the binding sites it lines).

Found with

  • EDO · 1,2-ethanediol

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.